Aziz Mottiwala was named President and Chief Executive Officer of RxSight, Inc. As of November 6, 2026, RxSight, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on July 15, 2026, naming 2 appointments (Form 8-K, July 15, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like RxSight, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
RxSight, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-07-15. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as RxSight, Inc. files it.
Also on the record for RxSight, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 2, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 5.1% of the class | 5%+ stakes | Source |
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock Portfolio Management LLC | 8.4% of the class | 5%+ stakes | Source |
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.9% of the class | 5%+ stakes | Source |
| August 19, 2026 | Stake report, Schedule 13G, by Point72 Asset Management, L.P. | 6% of the class | 5%+ stakes | Source |
| August 4, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 7.3% of the class | 5%+ stakes | Source |
| July 17, 2026 | Stake report, Schedule 13G, by BlackRock Portfolio Management LLC | 7.2% of the class | 5%+ stakes | Source |
| May 13, 2026 | Stake report, Schedule 13G/A, by Artisan Partners Asset Management Inc. | 5% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 3, 2026 | Stake report, Schedule 13G, by Artisan Partners Asset Management Inc. | 5.2% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by RA Capital Management, L.P. | — | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G/A, by Artisan Partners Asset Management Inc. | 4.3% of the class | 5%+ stakes | Source |
| November 4, 2025 | Stake report, Schedule 13G/A, by Millennium Management LLC | 5.4% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs RxSight, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on RxSight, Inc. and the records around it.
RxSight, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Artisan Partners Asset Management Inc. also filed stake reports on 16 other companies: Ascendis Pharma A/S (Aug 2026), AXALTA COATING SYSTEMS LTD. (Aug 2026), iRhythm Holdings, Inc. (Aug 2026)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
Watch RxSight, Inc.
Get an email when RxSight, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on RxSight, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on RxSight, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RxSight, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-15 | In | President and Chief Executive Officer | 8-K, 2026-07-15 | ||
| 2026-07-15 | In | 8-K, 2026-07-15 |
Who leads RxSight, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President and Chief Executive Officer: Aziz Mottiwala, appointed (filed 2026-07-15).
New leaders reset buying decisions — get the Full Report on RxSight, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President and Chief Executive Officer at RxSight, Inc., with the record behind each one.
Find candidates like President and Chief Executive Officer at RxSight, Inc.Every change, in the filing's words
Appointed: Aziz Mottiwala, President and Chief Executive Officer
On July 13, 2026, the Board of Directors (the "Board") of RxSight, Inc. (the "Company") appointed Aziz Mottiwala to serve as the Company's President and Chief Executive Officer, effective as of Mr. Mottiwala's first day of employment with the Company, which is expected to be July 20, 2026 (the "Effective Date"), replacing Ron Kurtz, M.D. in such roles.
Appointed: Aziz Mottiwala
On July 13, 2026, the Board appointed Mr. Mottiwala to fill the resulting vacancy, effective as of the Effective Date.
- Dr. Kurtz has served as the Company's President and Chief Executive Officer since 2016 and will transition to serve as the Company's Chief Medical Officer effective upon Mr. Mottiwala's appointment.
- Prior to joining the Company, Mr. Mottiwala, age 48, served as Chief Commercial Officer of Tarsus Pharmaceuticals, a pharmaceutical company, from August 2020 to July 2026.
- Mr. Mottiwala has served on the board of directors of OneOC, a non-profit organization based in Orange County, California since March 2018, and OCTANe, a convening organization of the Southern California technology and medical technology business ecosystem, since July 2021.
- Mr. Mottiwala previously served as Chief Commercial Officer of Opiant Pharmaceuticals, Inc. ("Opiant"), a previously publicly-traded pharmaceutical company specializing in medicines for the treatment of addictions and drug overdose from September 2019 to August 2020.
- Prior to Opiant, Mr. Mottiwala served as Senior Vice President of Sales and Marketing and Head of Commercial at Avanir Pharmaceuticals, Inc. ("Avanir"), a pharmaceutical company specializing in medicines to treat nervous system disorders from July 2017 to September 2019.
Tools for this story
Each opens in a new tab, filled in for RxSight, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.